Ignite Creation Date:
2024-05-05 @ 5:17 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00422487
Status:
COMPLETED
Last Update Posted:
2015-05-01
First Post:
2007-01-15
Brief Title:
Safety and Tolerability Study of MBX-2044 in Patients With Type 2 Diabetes
Sponsor:
CymaBay Therapeutics Inc
Organization:
CymaBay Therapeutics Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Type 2 Diabetes Mellitus |
Keywords:
| Name | View |
|---|---|
| Type 2 Diabetes Mellitus | View |